DE60210058D1 - Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten - Google Patents

Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten

Info

Publication number
DE60210058D1
DE60210058D1 DE60210058T DE60210058T DE60210058D1 DE 60210058 D1 DE60210058 D1 DE 60210058D1 DE 60210058 T DE60210058 T DE 60210058T DE 60210058 T DE60210058 T DE 60210058T DE 60210058 D1 DE60210058 D1 DE 60210058D1
Authority
DE
Germany
Prior art keywords
alkoxycarbonylamino
antagonists
heteroaryl
carboxylene
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60210058T
Other languages
English (en)
Other versions
DE60210058T2 (de
Inventor
Javier Lopez-Tapia
Dov Nitzan
Counde O'yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE60210058D1 publication Critical patent/DE60210058D1/de
Application granted granted Critical
Publication of DE60210058T2 publication Critical patent/DE60210058T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
DE60210058T 2001-03-02 2002-02-25 Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten Expired - Fee Related DE60210058T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27284901P 2001-03-02 2001-03-02
US272849P 2001-03-02
PCT/EP2002/001942 WO2002070514A1 (en) 2001-03-02 2002-02-25 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists

Publications (2)

Publication Number Publication Date
DE60210058D1 true DE60210058D1 (de) 2006-05-11
DE60210058T2 DE60210058T2 (de) 2006-11-09

Family

ID=23041569

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60210058T Expired - Fee Related DE60210058T2 (de) 2001-03-02 2002-02-25 Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten

Country Status (14)

Country Link
US (1) US6569860B2 (de)
EP (1) EP1368345B1 (de)
JP (1) JP2004526721A (de)
KR (1) KR100589990B1 (de)
CN (1) CN1280289C (de)
AR (1) AR033429A1 (de)
AT (1) ATE321041T1 (de)
BR (1) BR0207730A (de)
CA (1) CA2438813C (de)
DE (1) DE60210058T2 (de)
ES (1) ES2260425T3 (de)
MX (1) MXPA03007864A (de)
WO (1) WO2002070514A1 (de)
ZA (1) ZA200306283B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040054008A1 (en) 2002-09-13 2004-03-18 Tohru Araki Medicament for treatment of nocturia
JP2006517576A (ja) * 2003-02-14 2006-07-27 メディカル リサーチ カウンシル 病理的子宮症状の治療のためのｉｐレセプターアンタゴニスト
WO2007046646A1 (en) * 2005-10-20 2007-04-26 Lg Chem, Ltd. Novel organic silane compound
KR100840114B1 (ko) * 2005-10-20 2008-06-19 주식회사 엘지화학 점착제 조성물
AR069650A1 (es) * 2007-12-14 2010-02-10 Actelion Pharmaceuticals Ltd Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano
US9321745B2 (en) * 2013-03-12 2016-04-26 Allergan, Inc. Inhibition of neovascularization by inhibition of prostanoid IP receptors
WO2014143591A1 (en) 2013-03-12 2014-09-18 Allergan, Inc. Inhibition of neovascularization by simultaneous inhibition of prostanoid ip and ep4 receptors
SG11202008560VA (en) 2018-03-08 2020-10-29 Incyte Corp AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
EP4119138A1 (de) * 2021-07-12 2023-01-18 Universität Hamburg Dhodh-inhibitoren und ihre verwendung als antivirale mittel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908842A (en) 1995-12-08 1999-06-01 Merck & Co., Inc. Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
US6184242B1 (en) 1997-09-04 2001-02-06 Syntex Usa (Llc) 2-(substituted-phenyl)amino-imidazoline derivatives
WO1999026925A1 (fr) * 1997-11-26 1999-06-03 Yoshitomi Pharmaceutical Industries, Ltd. Inhibiteurs de tryptase comprenant des composants d'amide heterocycliques
ATE287875T1 (de) * 1998-10-06 2005-02-15 Dainippon Pharmaceutical Co 2,3-disubstituierte pyridinderivate, verfahren zur derren herstellung, sie enthaltende wirkstoffzubereitungen und zwischenprodukte für die herstellung
US6335459B1 (en) * 1998-12-23 2002-01-01 Syntex (U.S.A.) Llc Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators
SK1812002A3 (en) * 1999-08-12 2003-02-04 Pharmacia Italia Spa 3(5)-Amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
CN1241909C (zh) * 2000-03-16 2006-02-15 弗·哈夫曼-拉罗切有限公司 用作ip拮抗剂的羧酸衍生物

Also Published As

Publication number Publication date
CA2438813A1 (en) 2002-09-12
US20020169171A1 (en) 2002-11-14
EP1368345A1 (de) 2003-12-10
KR20030078962A (ko) 2003-10-08
CN1280289C (zh) 2006-10-18
AR033429A1 (es) 2003-12-17
WO2002070514A1 (en) 2002-09-12
ATE321041T1 (de) 2006-04-15
ZA200306283B (en) 2004-11-15
BR0207730A (pt) 2004-03-23
EP1368345B1 (de) 2006-03-22
JP2004526721A (ja) 2004-09-02
DE60210058T2 (de) 2006-11-09
ES2260425T3 (es) 2006-11-01
US6569860B2 (en) 2003-05-27
KR100589990B1 (ko) 2006-06-15
CA2438813C (en) 2008-07-29
CN1494544A (zh) 2004-05-05
MXPA03007864A (es) 2003-12-04

Similar Documents

Publication Publication Date Title
DE60218340D1 (de) 5,6-diaryl-pyrazineamidderivate als cb1 antagonisten
DE60331751D1 (de) N-substituierte 2-oxodihydropyridinderivate als npy antagonisten
ATE441631T1 (de) Phenylpiperidinderivate als serotonin- wiederaufnahmehemmer
ATE506360T1 (de) Neue benzimidazolderivate
ATE319451T1 (de) Tetrahydrochinolin-derivate
DK1427709T3 (da) 3-substituerede 4-pyrimidonderivater
DE60110844D1 (de) Chinazolone derivate als alfa 1a/b adrenozeptor antagonisten
NO20041235L (no) Kinolinderivater som neuropeptid Y antagonister
ATE392897T1 (de) Chinolinderivate als npy antagonisten
NO20032142L (no) Substituerte 2-fenylaminoimidazolin-fenylketon-derivater som IP-antagonister
DE50202178D1 (de) Neue sulfonat-substituierte pyrazolopyridinderivate
DE60118569D1 (de) 4-phenylpyridin-derivate als neurokinin-1-rezeptor-antagonisten
DE60114852D1 (de) Chinazolin-derivate als alpha-1 adrenerge antagonisten
EE200300447A (et) Asendatud bensofuraan-2-karboksamiidide derivaadid
DE60222693D1 (de) Nk1-antagonisten
DE60207399D1 (de) Alkoxycarbonylaminobenzoesäure- oder alkoxycarbonylaminotetrazolylphenylderivate als ip-antagonisten
DE60017110D1 (de) Biphenylderivate als neurokinin-1 antagonisten
DE60210058D1 (de) Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
ATE418542T1 (de) Als ccr5-antagonisten verwendbare aryloxim- piperazine
DE50206910D1 (de) Substituierte y-lactonverbindungen als nmda-antagonisten
DE60201463D1 (de) Indanon-Derivate als Duftstoffe
ATE382601T1 (de) Substituierte 4-aminocyclohexanolderivate
DE60202381D1 (de) Paroxetin-n-formyl-derivate
IS7022A (is) Nýjar indólafleiður

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee